6
H index
1
i10 index
81
Citations
László Gulácsi : Citation Profile
Budapesti Corvinus Egyetem | RESEARCH PRODUCTION: 23 Articles RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
7 years (2007 - 2014). Relations with other researchers
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with László Gulácsi. | Is cited by:
| Cites to:
|
Main data
Where László Gulácsi has published?
| Journals with more than one article published | # docs |
|---|---|
| The European Journal of Health Economics | 18 |
| Health Policy | 2 |
| Society and Economy | 2 |
Works by László Gulácsi:
Year  | Title | Type | Cited |
|---|---|---|---|
| 2012 | Comparing cost-sharing practices for pharmaceuticals and health care services among four central European countries In: Society and Economy. [Full Text][Citation analysis] | article | 1 |
| 2012 | Preferences of Hungarian consumers for quality, access and price attributes of health care services — result of a discrete choice experiment In: Society and Economy. [Full Text][Citation analysis] | article | 7 |
| 2011 | User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders In: Health Policy. [Full Text][Citation analysis] | article | 7 |
| 2009 | Quality management and patient safety: Survey results from 102 Hungarian hospitals In: Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2007 | Verseny az egészségügyben. Egyesült államokbeli és nyugat-európai példák In: Közgazdasági Szemle (Economic Review - monthly of the Hungarian Academy of Sciences). [Full Text][Citation analysis] | article | 0 |
| 2010 | The disease burden of colorectal cancer in Hungary In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2010 | Future challenges for health economics and health technology assessment of biological drugs In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2012 | Health economics and health technology assessment in Central and Eastern Europe: a dose of reality In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 7 |
| 2014 | Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2014 | Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 5 |
| 2014 | Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2014 | Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 7 |
| 2014 | Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 7 |
| 2014 | Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 11 |
| 2014 | Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2014 | Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 5 |
| 2014 | Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2014 | Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 1 |
| 2014 | Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 5 |
| 2014 | Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 2 |
| 2014 | HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2014 | The link between past informal payments and willingness of the Hungarian population to pay formal fees for health care services: results from a contingent valuation study In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
| 2007 | The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 4 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated February, 4 2025. Contact: CitEc Team